Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
PUT
DraftKings
DKNG
$12.6B
| $141M | 0.02% |
3,786,000
+768,100
| +25% | +$30.5M |
|
552
Comcast
CMCSA
$92.9B
| $141M | 0.02% |
3,748,355
-2,949,149
| -44% | -$122M |
|
553
PUT
Affirm
AFRM
$26.2B
| $140M | 0.02% |
2,304,500
-405,000
| -15% | -$22.5M |
|
554
Caesars Entertainment
CZR
$6.04B
| $140M | 0.02% |
4,191,175
+761,536
| +22% | +$30.2M |
|
555
CALL
Lennar Class A
LEN
$21.1B
| $140M | 0.02% |
1,059,755
+370,434
| +54% | +$60.2M |
|
556
C.H. Robinson
CHRW
$17.5B
| $140M | 0.02% |
1,353,806
+148,866
| +12% | +$16M |
|
557
CALL
Vertex Pharmaceuticals
VRTX
$131B
| $140M | 0.02% |
347,100
+137,600
| +66% | +$63.8M |
|
558
PUT
3M
MMM
$94.2B
| $140M | 0.02% |
1,082,300
-149,400
| -12% | -$19.6M |
|
559
American Tower
AMT
$81.2B
| $140M | 0.02% |
761,064
+612,723
| +413% | +$127M |
|
560
Globant
GLOB
$1.77B
| $139M | 0.02% |
650,333
+647,432
| +22,318% | +$141M |
|
561
CALL
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$3.89B
| $139M | 0.02% |
6,279,900
+525,300
| +9% | +$12.7M |
|
562
Prologis
PLD
$134B
| $139M | 0.02% |
1,313,807
+1,064,960
| +428% | +$122M |
|
563
CALL
Thermo Fisher Scientific
TMO
$220B
| $137M | 0.02% |
264,000
-47,300
| -15% | -$26M |
|
564
PUT
Merck
MRK
$334B
| $137M | 0.02% |
1,378,500
| – | – |
|
565
Regeneron Pharmaceuticals
REGN
$83B
| $137M | 0.02% |
192,346
+122,086
| +174% | +$102M |
|
566
Amgen
AMGN
$226B
| $137M | 0.02% |
524,503
+516,699
| +6,621% | +$153M |
|
567
PUT
Intuitive Surgical
ISRG
$142B
| $137M | 0.02% |
261,700
-99,400
| -28% | -$51.8M |
|
568
MongoDB
MDB
$38B
| $137M | 0.02% |
586,320
+244,200
| +71% | +$69M |
|
569
ServiceNow
NOW
$132B
| $136M | 0.02% |
642,360
+504,690
| +367% | +$102M |
|
570
CALL
iShares Semiconductor ETF
SOXX
$46.6B
| $135M | 0.02% |
628,100
-139,100
| -18% | -$31M |
|
571
RTX Corp
RTX
$297B
| $135M | 0.02% |
1,165,691
+1,056,905
| +972% | +$128M |
|
572
CALL
Zillow
Z
$8.08B
| $135M | 0.02% |
1,819,900
+76,400
| +4% | +$5.46M |
|
573
Danaher
DHR
$143B
| $135M | 0.02% |
586,909
-84,477
| -13% | -$20.8M |
|
574
DT Midstream
DTM
$13.8B
| $135M | 0.02% |
1,353,329
+1,129,279
| +504% | +$108M |
|
575
Evergy
EVRG
$19.3B
| $134M | 0.02% |
2,182,316
+813,377
| +59% | +$50.3M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.